Atlas Trials

A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol

Clinical trial NCT04039919 · TERMINATED

Trial details

NCT number
NCT04039919
Sponsor
UCB Biopharma S.P.R.L.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2019-07-17
Primary completion
2020-05-22
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.